No fewer than nine former directors of the CDC, serving under both Democratic and Republican presidents, have said every American should be alarmed at what is happening on HHS Secretary Robert F ...

Estimated to have saved European healthcare systems €56 billion and provided 5.8 million patient treatment days to date, biosimilars - clinically equivalent alternatives to original biologic drugs - ...

UK biotech OMass Therapeutics has revealed its first major pharma partnership, with Roche's Genentech unit paying $20 million upfront to tap into its expertise and find small-molecule therapies for ...

Newcastle's NIHR Innovation Observatory was set up nearly a decade ago to identify emerging medicines, diagnostics, devices and digital technologies that have the potential to "transform care, reduce ...

The results of the 6,105-patient VICTOR study showed that Verquvo (vericiguat) was unable to meet its objective of reducing the rate of heart failure hospitalisations or cardiovascular death in ...

Orr Inbar is a data scientist and expert in AI-powered drug development, with over 10 years of leadership experience helping small to mid-sized start-ups in Israel and the US to grow, innovate, scale, ...

It emerged this morning that private equity group CapVest has agreed to buy a majority stake in Stada from investment groups Bain Capital and Cinven in a deal that market watchers say values it at ...

The future of obesity therapeutics is being written now – be a part of it! Visit the full agenda and speakers here: ...

In the shadow of this excitement, the 3rd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia this December as your insider access pass to the future of cell therapy innovation.

Be at the forefront of the next era in evidence generation at the IMPACCT Real-World Evidence Summit West, where real-world data meets AI-powered insights and cross-functional collaboration. With new ...

The 2nd Cell & Gene Therapy Regulatory Affairs Summit (December 2-4, Washington, D.C.) is the only industry-led event dedicated exclusively to CGT regulatory strategy. Designed for professionals ...

One commentator, Prof Morris Brown of Queen Mary University of London (QMUL), who is an expert in hypertension, said that ...